APO Research

APO RESEARCH · REPORT

Digestive System Disease Treatment

Selected research

Market Structure

Global Digestive System Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Digestive System Disease Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Digestive System Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Digestive System Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digestive System Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Digestive System Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Digestive System Disease Treatment include Zhengdatianqing Pharma, Takeda Pharma, Eisai Co., Teva, Sun Pharma, Shanghai Shangyao, Sanofi, Luoxin Pharma and LIVZON, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Digestive System Disease Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Digestive System Disease Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Digestive System Disease Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Digestive System Disease Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Digestive System Disease Treatment Segment by Company

Zhengdatianqing Pharma

Takeda Pharma

Eisai Co.

Teva

Sun Pharma

Shanghai Shangyao

Sanofi

Luoxin Pharma

LIVZON

Pfizer

Eastchina Pharma

Bayer

AbbVie

AstraZeneca

Zydus Cadila

Viatris

Intercept

Heron Therapeutics

Dr Falk Pharma

Bausch Health

AOSAIKANG Pharma

Digestive System Disease Treatment Segment by Type

Injection

Tablet

Caspuse

Other

Digestive System Disease Treatment Segment by Application

Hospital

Retail Pharmacy

Other

Digestive System Disease Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digestive System Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digestive System Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digestive System Disease Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Digestive System Disease Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Digestive System Disease Treatment industry.

Chapter 3: Detailed analysis of Digestive System Disease Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digestive System Disease Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digestive System Disease Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Injection Table 3. Key Players of Tablet Table 4. Key Players of Caspuse Table 3. Key Players of Other Table 4. Global Digestive System Disease Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Retail Pharmacy Table 7. Key Players of Other Table 8. Global Digestive System Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Digestive System Disease Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Digestive System Disease Treatment Market Share by Region (2021-2026) Table 11. Global Digestive System Disease Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Digestive System Disease Treatment Market Share by Region (2027-2032) Table 13. Digestive System Disease Treatment Industry Trends Table 14. Digestive System Disease Treatment Industry Drivers Table 15. Digestive System Disease Treatment Industry Opportunities and Challenges Table 16. Digestive System Disease Treatment Industry Restraints Table 17. Global Digestive System Disease Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Digestive System Disease Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Digestive System Disease Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Digestive System Disease Treatment Key Company Head Office and Area Served Table 21. Global Digestive System Disease Treatment Company, Product Type & Application Table 22. Global Digestive System Disease Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Digestive System Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Digestive System Disease Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Digestive System Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Digestive System Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Digestive System Disease Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Digestive System Disease Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Digestive System Disease Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Digestive System Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Digestive System Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Digestive System Disease Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Digestive System Disease Treatment Revenue Market Share by Application (2027-2032) Table 35. Zhengdatianqing Pharma Company Information Table 36. Zhengdatianqing Pharma Business Overview Table 37. Zhengdatianqing Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Zhengdatianqing Pharma Digestive System Disease Treatment Product Portfolio Table 39. Zhengdatianqing Pharma Recent Development Table 40. Takeda Pharma Company Information Table 41. Takeda Pharma Business Overview Table 42. Takeda Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Takeda Pharma Digestive System Disease Treatment Product Portfolio Table 44. Takeda Pharma Recent Development Table 45. Eisai Co. Company Information Table 46. Eisai Co. Business Overview Table 47. Eisai Co. Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Eisai Co. Digestive System Disease Treatment Product Portfolio Table 49. Eisai Co. Recent Development Table 50. Teva Company Information Table 51. Teva Business Overview Table 52. Teva Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Teva Digestive System Disease Treatment Product Portfolio Table 54. Teva Recent Development Table 55. Sun Pharma Company Information Table 56. Sun Pharma Business Overview Table 57. Sun Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Sun Pharma Digestive System Disease Treatment Product Portfolio Table 59. Sun Pharma Recent Development Table 60. Shanghai Shangyao Company Information Table 61. Shanghai Shangyao Business Overview Table 62. Shanghai Shangyao Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Shanghai Shangyao Digestive System Disease Treatment Product Portfolio Table 64. Shanghai Shangyao Recent Development Table 65. Sanofi Company Information Table 66. Sanofi Business Overview Table 67. Sanofi Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Sanofi Digestive System Disease Treatment Product Portfolio Table 69. Sanofi Recent Development Table 70. Luoxin Pharma Company Information Table 71. Luoxin Pharma Business Overview Table 72. Luoxin Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Luoxin Pharma Digestive System Disease Treatment Product Portfolio Table 74. Luoxin Pharma Recent Development Table 75. LIVZON Company Information Table 76. LIVZON Business Overview Table 77. LIVZON Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. LIVZON Digestive System Disease Treatment Product Portfolio Table 79. LIVZON Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Pfizer Digestive System Disease Treatment Product Portfolio Table 84. Pfizer Recent Development Table 85. Eastchina Pharma Company Information Table 86. Eastchina Pharma Business Overview Table 87. Eastchina Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Eastchina Pharma Digestive System Disease Treatment Product Portfolio Table 89. Eastchina Pharma Recent Development Table 90. Bayer Company Information Table 91. Bayer Business Overview Table 92. Bayer Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Bayer Digestive System Disease Treatment Product Portfolio Table 94. Bayer Recent Development Table 95. AbbVie Company Information Table 96. AbbVie Business Overview Table 97. AbbVie Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. AbbVie Digestive System Disease Treatment Product Portfolio Table 99. AbbVie Recent Development Table 100. AstraZeneca Company Information Table 101. AstraZeneca Business Overview Table 102. AstraZeneca Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. AstraZeneca Digestive System Disease Treatment Product Portfolio Table 104. AstraZeneca Recent Development Table 105. Zydus Cadila Company Information Table 106. Zydus Cadila Business Overview Table 107. Zydus Cadila Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Zydus Cadila Digestive System Disease Treatment Product Portfolio Table 109. Zydus Cadila Recent Development Table 110. Viatris Company Information Table 111. Viatris Business Overview Table 112. Viatris Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Viatris Digestive System Disease Treatment Product Portfolio Table 114. Viatris Recent Development Table 115. Intercept Company Information Table 116. Intercept Business Overview Table 117. Intercept Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Intercept Digestive System Disease Treatment Product Portfolio Table 119. Intercept Recent Development Table 120. Heron Therapeutics Company Information Table 121. Heron Therapeutics Business Overview Table 122. Heron Therapeutics Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Heron Therapeutics Digestive System Disease Treatment Product Portfolio Table 124. Heron Therapeutics Recent Development Table 125. Dr Falk Pharma Company Information Table 126. Dr Falk Pharma Business Overview Table 127. Dr Falk Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Dr Falk Pharma Digestive System Disease Treatment Product Portfolio Table 129. Dr Falk Pharma Recent Development Table 130. Bausch Health Company Information Table 131. Bausch Health Business Overview Table 132. Bausch Health Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Bausch Health Digestive System Disease Treatment Product Portfolio Table 134. Bausch Health Recent Development Table 135. AOSAIKANG Pharma Company Information Table 136. AOSAIKANG Pharma Business Overview Table 137. AOSAIKANG Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 138. AOSAIKANG Pharma Digestive System Disease Treatment Product Portfolio Table 139. AOSAIKANG Pharma Recent Development Table 140. North America Digestive System Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 141. North America Digestive System Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 142. North America Digestive System Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 143. North America Digestive System Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 144. North America Digestive System Disease Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Digestive System Disease Treatment Market Size by Country (2021-2026) Table 146. North America Digestive System Disease Treatment Market Size by Country (2027-2032) Table 147. Europe Digestive System Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 148. Europe Digestive System Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 149. Europe Digestive System Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 150. Europe Digestive System Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 151. Europe Digestive System Disease Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Digestive System Disease Treatment Market Size by Country (2021-2026) Table 153. Europe Digestive System Disease Treatment Market Size by Country (2027-2032) Table 154. China Digestive System Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 155. China Digestive System Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 156. China Digestive System Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 157. China Digestive System Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 158. Asia Digestive System Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 159. Asia Digestive System Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 160. Asia Digestive System Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 161. Asia Digestive System Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 162. Asia Digestive System Disease Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Asia Digestive System Disease Treatment Market Size by Country (2021-2026) Table 164. Asia Digestive System Disease Treatment Market Size by Country (2027-2032) Table 165. South America, Middle East & Africa Digestive System Disease Treatment Market Size by Type (2021-2026) & (US$ Million) Table 166. South America, Middle East & Africa Digestive System Disease Treatment Market Size by Type (2027-2032) & (US$ Million) Table 167. South America, Middle East & Africa Digestive System Disease Treatment Market Size by Application (2021-2026) & (US$ Million) Table 168. South America, Middle East & Africa Digestive System Disease Treatment Market Size by Application (2027-2032) & (US$ Million) Table 169. South America, Middle East & Africa Digestive System Disease Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. South America, Middle East & Africa Digestive System Disease Treatment Market Size by Country (2021-2026) Table 171. South America, Middle East & Africa Digestive System Disease Treatment Market Size by Country (2027-2032) Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Digestive System Disease Treatment Product Image Figure 2. Global Digestive System Disease Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Digestive System Disease Treatment Market Share by Type: 2025 VS 2032 Figure 4. Injection Image Figure 5. Tablet Image Figure 6. Caspuse Image Figure 7. Other Image Figure 8. Global Digestive System Disease Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Digestive System Disease Treatment Market Share by Application: 2025 VS 2032 Figure 10. Hospital Image Figure 11. Retail Pharmacy Image Figure 12. Other Image Figure 13. Global Digestive System Disease Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 15. Global Digestive System Disease Treatment Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Digestive System Disease Treatment Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Digestive System Disease Treatment Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Digestive System Disease Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Digestive System Disease Treatment Revenue Market Share by Type (2021-2032) Figure 22. Global Digestive System Disease Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Digestive System Disease Treatment Revenue Market Share by Application (2021-2032) Figure 24. North America Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 25. North America Digestive System Disease Treatment Market Share by Type (2021-2032) Figure 26. North America Digestive System Disease Treatment Market Share by Application (2021-2032) Figure 27. North America Digestive System Disease Treatment Market Share by Country (2021-2032) Figure 28. United States Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Canada Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe Digestive System Disease Treatment Market Share by Type (2021-2032) Figure 33. Europe Digestive System Disease Treatment Market Share by Application (2021-2032) Figure 34. Europe Digestive System Disease Treatment Market Share by Country (2021-2032) Figure 35. Germany Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 36. France Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Italy Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Russia Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China Digestive System Disease Treatment Market Share by Type (2021-2032) Figure 43. China Digestive System Disease Treatment Market Share by Application (2021-2032) Figure 44. Asia Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 45. Asia Digestive System Disease Treatment Market Share by Type (2021-2032) Figure 46. Asia Digestive System Disease Treatment Market Share by Application (2021-2032) Figure 47. Asia Digestive System Disease Treatment Market Share by Country (2021-2032) Figure 48. Japan Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 52. India Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 53. Australia Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Digestive System Disease Treatment Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Digestive System Disease Treatment Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Digestive System Disease Treatment Market Share by Country (2021-2032) Figure 58. Brazil Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 63. UAE Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Chile Digestive System Disease Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablet
  • Caspuse
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Zhengdatianqing Pharma
  • Takeda Pharma
  • Eisai Co.
  • Teva
  • Sun Pharma
  • Shanghai Shangyao
  • Sanofi
  • Luoxin Pharma
  • LIVZON
  • Pfizer
  • Eastchina Pharma
  • Bayer
  • AbbVie
  • AstraZeneca
  • Zydus Cadila
  • Viatris
  • Intercept
  • Heron Therapeutics
  • Dr Falk Pharma
  • Bausch Health
  • AOSAIKANG Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Digestive System Disease Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Tablet
  6. 1.2.4 Caspuse
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Digestive System Disease Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Retail Pharmacy
  12. 1.3.4 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Digestive System Disease Treatment Growth Trends by Region
  15. 1.5.1 Global Digestive System Disease Treatment Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Digestive System Disease Treatment Market Size by Region (2021-2026)
  17. 1.5.3 Digestive System Disease Treatment Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Digestive System Disease Treatment Market Dynamics
  1. 2.1 Digestive System Disease Treatment Industry Trends
  2. 2.2 Digestive System Disease Treatment Industry Drivers
  3. 2.3 Digestive System Disease Treatment Industry Opportunities and Challenges
  4. 2.4 Digestive System Disease Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Digestive System Disease Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Digestive System Disease Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Digestive System Disease Treatment Key Company Head office and Area Served
  4. 3.4 Global Digestive System Disease Treatment Company, Product Type & Application
  5. 3.5 Global Digestive System Disease Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Digestive System Disease Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Digestive System Disease Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Digestive System Disease Treatment Tier 1, Tier 2, and Tier 3
4 Digestive System Disease Treatment Market by Type
  1. 4.1 Global Digestive System Disease Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Digestive System Disease Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Digestive System Disease Treatment Market Size Share by Type (2021-2032)
5 Digestive System Disease Treatment Market by Application
  1. 5.1 Global Digestive System Disease Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Digestive System Disease Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Digestive System Disease Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Zhengdatianqing Pharma
  2. 6.1.1 Zhengdatianqing Pharma Company Information
  3. 6.1.2 Zhengdatianqing Pharma Business Overview
  4. 6.1.3 Zhengdatianqing Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Zhengdatianqing Pharma Digestive System Disease Treatment Product Portfolio
  6. 6.1.5 Zhengdatianqing Pharma Recent Developments
  7. 6.2 Takeda Pharma
  8. 6.2.1 Takeda Pharma Company Information
  9. 6.2.2 Takeda Pharma Business Overview
  10. 6.2.3 Takeda Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Takeda Pharma Digestive System Disease Treatment Product Portfolio
  12. 6.2.5 Takeda Pharma Recent Developments
  13. 6.3 Eisai Co.
  14. 6.3.1 Eisai Co. Company Information
  15. 6.3.2 Eisai Co. Business Overview
  16. 6.3.3 Eisai Co. Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Eisai Co. Digestive System Disease Treatment Product Portfolio
  18. 6.3.5 Eisai Co. Recent Developments
  19. 6.4 Teva
  20. 6.4.1 Teva Company Information
  21. 6.4.2 Teva Business Overview
  22. 6.4.3 Teva Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Teva Digestive System Disease Treatment Product Portfolio
  24. 6.4.5 Teva Recent Developments
  25. 6.5 Sun Pharma
  26. 6.5.1 Sun Pharma Company Information
  27. 6.5.2 Sun Pharma Business Overview
  28. 6.5.3 Sun Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Sun Pharma Digestive System Disease Treatment Product Portfolio
  30. 6.5.5 Sun Pharma Recent Developments
  31. 6.6 Shanghai Shangyao
  32. 6.6.1 Shanghai Shangyao Company Information
  33. 6.6.2 Shanghai Shangyao Business Overview
  34. 6.6.3 Shanghai Shangyao Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Shanghai Shangyao Digestive System Disease Treatment Product Portfolio
  36. 6.6.5 Shanghai Shangyao Recent Developments
  37. 6.7 Sanofi
  38. 6.7.1 Sanofi Company Information
  39. 6.7.2 Sanofi Business Overview
  40. 6.7.3 Sanofi Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Sanofi Digestive System Disease Treatment Product Portfolio
  42. 6.7.5 Sanofi Recent Developments
  43. 6.8 Luoxin Pharma
  44. 6.8.1 Luoxin Pharma Company Information
  45. 6.8.2 Luoxin Pharma Business Overview
  46. 6.8.3 Luoxin Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Luoxin Pharma Digestive System Disease Treatment Product Portfolio
  48. 6.8.5 Luoxin Pharma Recent Developments
  49. 6.9 LIVZON
  50. 6.9.1 LIVZON Company Information
  51. 6.9.2 LIVZON Business Overview
  52. 6.9.3 LIVZON Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 LIVZON Digestive System Disease Treatment Product Portfolio
  54. 6.9.5 LIVZON Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Pfizer Digestive System Disease Treatment Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 Eastchina Pharma
  62. 6.11.1 Eastchina Pharma Company Information
  63. 6.11.2 Eastchina Pharma Business Overview
  64. 6.11.3 Eastchina Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Eastchina Pharma Digestive System Disease Treatment Product Portfolio
  66. 6.11.5 Eastchina Pharma Recent Developments
  67. 6.12 Bayer
  68. 6.12.1 Bayer Company Information
  69. 6.12.2 Bayer Business Overview
  70. 6.12.3 Bayer Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Bayer Digestive System Disease Treatment Product Portfolio
  72. 6.12.5 Bayer Recent Developments
  73. 6.13 AbbVie
  74. 6.13.1 AbbVie Company Information
  75. 6.13.2 AbbVie Business Overview
  76. 6.13.3 AbbVie Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 AbbVie Digestive System Disease Treatment Product Portfolio
  78. 6.13.5 AbbVie Recent Developments
  79. 6.14 AstraZeneca
  80. 6.14.1 AstraZeneca Company Information
  81. 6.14.2 AstraZeneca Business Overview
  82. 6.14.3 AstraZeneca Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 AstraZeneca Digestive System Disease Treatment Product Portfolio
  84. 6.14.5 AstraZeneca Recent Developments
  85. 6.15 Zydus Cadila
  86. 6.15.1 Zydus Cadila Company Information
  87. 6.15.2 Zydus Cadila Business Overview
  88. 6.15.3 Zydus Cadila Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Zydus Cadila Digestive System Disease Treatment Product Portfolio
  90. 6.15.5 Zydus Cadila Recent Developments
  91. 6.16 Viatris
  92. 6.16.1 Viatris Company Information
  93. 6.16.2 Viatris Business Overview
  94. 6.16.3 Viatris Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Viatris Digestive System Disease Treatment Product Portfolio
  96. 6.16.5 Viatris Recent Developments
  97. 6.17 Intercept
  98. 6.17.1 Intercept Company Information
  99. 6.17.2 Intercept Business Overview
  100. 6.17.3 Intercept Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Intercept Digestive System Disease Treatment Product Portfolio
  102. 6.17.5 Intercept Recent Developments
  103. 6.18 Heron Therapeutics
  104. 6.18.1 Heron Therapeutics Company Information
  105. 6.18.2 Heron Therapeutics Business Overview
  106. 6.18.3 Heron Therapeutics Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Heron Therapeutics Digestive System Disease Treatment Product Portfolio
  108. 6.18.5 Heron Therapeutics Recent Developments
  109. 6.19 Dr Falk Pharma
  110. 6.19.1 Dr Falk Pharma Company Information
  111. 6.19.2 Dr Falk Pharma Business Overview
  112. 6.19.3 Dr Falk Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Dr Falk Pharma Digestive System Disease Treatment Product Portfolio
  114. 6.19.5 Dr Falk Pharma Recent Developments
  115. 6.20 Bausch Health
  116. 6.20.1 Bausch Health Company Information
  117. 6.20.2 Bausch Health Business Overview
  118. 6.20.3 Bausch Health Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Bausch Health Digestive System Disease Treatment Product Portfolio
  120. 6.20.5 Bausch Health Recent Developments
  121. 6.21 AOSAIKANG Pharma
  122. 6.21.1 AOSAIKANG Pharma Company Information
  123. 6.21.2 AOSAIKANG Pharma Business Overview
  124. 6.21.3 AOSAIKANG Pharma Digestive System Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 AOSAIKANG Pharma Digestive System Disease Treatment Product Portfolio
  126. 6.21.5 AOSAIKANG Pharma Recent Developments
7 North America
  1. 7.1 North America Digestive System Disease Treatment Market Size (2021-2032)
  2. 7.2 North America Digestive System Disease Treatment Market Size by Type
  3. 7.2.1 North America Digestive System Disease Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Digestive System Disease Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Digestive System Disease Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Digestive System Disease Treatment Market Size by Application
  7. 7.3.1 North America Digestive System Disease Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Digestive System Disease Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Digestive System Disease Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Digestive System Disease Treatment Market Size by Country
  11. 7.4.1 North America Digestive System Disease Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Digestive System Disease Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Digestive System Disease Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Digestive System Disease Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Digestive System Disease Treatment Market Size (2021-2032)
  2. 8.2 Europe Digestive System Disease Treatment Market Size by Type
  3. 8.2.1 Europe Digestive System Disease Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Digestive System Disease Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Digestive System Disease Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Digestive System Disease Treatment Market Size by Application
  7. 8.3.1 Europe Digestive System Disease Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Digestive System Disease Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Digestive System Disease Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Digestive System Disease Treatment Market Size by Country
  11. 8.4.1 Europe Digestive System Disease Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Digestive System Disease Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Digestive System Disease Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Digestive System Disease Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Digestive System Disease Treatment Market Size (2021-2032)
  2. 9.2 China Digestive System Disease Treatment Market Size by Type
  3. 9.2.1 China Digestive System Disease Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Digestive System Disease Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Digestive System Disease Treatment Market Share by Type (2021-2032)
  6. 9.3 China Digestive System Disease Treatment Market Size by Application
  7. 9.3.1 China Digestive System Disease Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Digestive System Disease Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Digestive System Disease Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Digestive System Disease Treatment Market Size (2021-2032)
  2. 10.2 Asia Digestive System Disease Treatment Market Size by Type
  3. 10.2.1 Asia Digestive System Disease Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Digestive System Disease Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Digestive System Disease Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Digestive System Disease Treatment Market Size by Application
  7. 10.3.1 Asia Digestive System Disease Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Digestive System Disease Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Digestive System Disease Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Digestive System Disease Treatment Market Size by Country
  11. 10.4.1 Asia Digestive System Disease Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Digestive System Disease Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Digestive System Disease Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Digestive System Disease Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Digestive System Disease Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Digestive System Disease Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Digestive System Disease Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Digestive System Disease Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Digestive System Disease Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Digestive System Disease Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Digestive System Disease Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Digestive System Disease Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Digestive System Disease Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Digestive System Disease Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Digestive System Disease Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Digestive System Disease Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Digestive System Disease Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Digestive System Disease Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research